stockrow
Friday 6 November 2026
Export OPCH’s income statement to Excel — free account
Option Care Health, Inc.
OPCH Healthcare Medical Care Facilities
Option Care Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 billion, up 13.0% from fiscal 2024.
- Revenue
- +4.08%
- EPS
- +19.8%
- Free cash flow
- −17.0%
- Total debt
- −0.93%
Quarter to September 2026, against a year earlier
31.52
0.13
−0.41%
Follow OPCH
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
24.89 | 18.56 | 23.03 | 35.54 | 36.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 6 | 9 | 6 | 9 | 6 | 3 | 5 | 6 | 5 |
P/S ratio |
0.91 | 0.80 | 1.43 | 1.35 | 1.49 | 0.93 | 1.01 | 1.05 | 0.95 | 0.14 |
Altman Z-Score |
3.92 | 3.42 | 4.05 | 3.67 | 3.49 | 2.37 | 1.78 | 3.10 | 3.14 | 0.18 |
P/FCF ratio |
23.78 | 13.83 | 18.43 | 21.64 | 27.96 | 28.16 | 0.00 | 0.00 | 130.28 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.97 | 3.04 | 2.92 | 2.46 | 1.86 | 1.36 | 1.03 | 1.95 | (2.77) | (3.06) |
Beneish M-Score |
(2.38) | (2.51) | (2.65) | (2.54) | (2.53) | (2.65) | (2.62) | (0.01) | (3.01) | (2.25) |
P/Operating CF |
143.89 | 110.19 | 120.48 | 122.95 | 78.32 | 110.29 | 101.83 | 166.52 | 36.91 | (32.55) |
P/B ratio |
3.89 | 2.83 | 4.32 | 3.85 | 4.35 | 2.79 | 2.57 | 3.38 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.08 | 0.94 | 1.59 | 1.55 | 1.76 | 1.27 | 1.54 | 1.31 | 1.19 | 0.61 |
EV/EBITDA |
14.76 | 12.00 | 17.99 | 19.72 | 22.90 | 19.86 | 57.19 | 30.81 | 31.93 | 37.98 |
EV/Operating CF |
23.57 | 14.47 | 18.47 | 22.85 | 29.06 | 30.26 | 89.98 | 103.96 | 57.61 | (13.46) |
EV/FCF |
28.06 | 16.26 | 20.59 | 24.76 | 33.13 | 38.36 | (913.83) | (1,374.19) | 162.83 | (11.87) |
Quick Ratio |
0.85 | 1.05 | 1.17 | 1.19 | 1.00 | 0.99 | 1.19 | 1.44 | 1.24 | 0.91 |
Current Ratio |
1.53 | 1.70 | 1.77 | 1.76 | 1.55 | 1.51 | 1.69 | 1.95 | 1.77 | 1.33 |
Net Debt/EBITDA |
2.25 | 1.79 | 1.89 | 2.48 | 3.58 | 5.28 | 19.64 | 6.10 | 6.38 | 29.34 |
Debt/Assets |
33.59% | 32.47% | 33.03% | 34.19% | 38.19% | 42.47% | 49.68% | 37.77% | 79.69% | 74.70% |
Debt/Equity |
0.88 | 0.79 | 0.75 | 0.77 | 0.91 | 1.11 | 1.42 | 0.89 | (5.67) | 11.77 |
Asset Turnover |
1.64 | 1.51 | 1.36 | 1.34 | 1.26 | 1.16 | 1.15 | 1.91 | 3.03 | 1.65 |
Operating CF/Net income |
1.25 | 1.53 | 1.39 | 1.78 | 1.49 | (15.77) | (0.52) | (3.99) | 9.77 | 0.82 |
Capex/Depreciation |
(0.55) | (0.52) | (0.57) | (0.30) | (0.35) | (0.32) | (0.45) | (0.59) | (0.60) | (0.22) |
Interest Coverage |
6.19 | 6.56 | 6.14 | 4.46 | 2.85 | 1.03 | 0.00 | 0.84 | 0.62 | (0.29) |
| 15.20% | 14.99% | 19.03% | 11.75% | 12.77% | (0.84%) | (10.06%) | (2.36%) | (6.55%) | 90.57% | |
| 6.04% | 6.38% | 8.44% | 5.10% | 5.14% | (0.31%) | (3.78%) | (0.60%) | 0.64% | (9.13%) | |
ROIC |
9.37% | 9.57% | 9.19% | 6.96% | 5.62% | 3.39% | (0.01%) | 2.16% | 4.85% | (1.43%) |
Return on Tangible Assets |
36.11% | 31.62% | 44.77% | 28.02% | 38.64% | (2.35%) | (20.98%) | (1.91%) | 3.58% | (68.35%) |
Average Days of Receivables |
30.60 | 29.92 | 32.04 | 34.93 | 35.90 | 39.52 | 51.25 | 58.36 | 17.08 | 42.56 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
12.08% | 12.61% | 14.12% | 14.35% | 15.29% | 16.49% | 19.89% | 17.83% | 18.51% | 4.15% |
Intangible Assets out of Total Assets |
0.47 | 0.46 | 0.49 | 0.50 | 0.54 | 0.55 | 0.70 | 0.60 | 0.64 | 0.66 |
Share Based Compensation of Revenue |
0.71% | 0.72% | 0.71% | 0.43% | 0.28% | 0.10% | 0.18% | 0.11% | 0.08% | 0.19% |
Graham Net Nets |
(0.17) | (0.17) | (0.11) | (0.14) | (0.18) | (0.34) | (0.48) | (0.18) | (0.29) | (3.02) |
Graham Number |
15.35 | 15.17 | 16.32 | 11.96 | 10.74 | 0.00 | 0.00 | 0.00 | 6.29 | 8.43 |
Earnings Yield |
4.02% | 5.39% | 4.34% | 2.81% | 2.76% | (0.26%) | (3.29%) | (11.12%) | (24.18%) | (39.57%) |
Free Cash Flow Yield |
4.20% | 7.23% | 5.43% | 4.62% | 3.58% | 3.55% | (0.17%) | (0.09%) | 0.77% | (37.02%) |
Revenue per Share |
34.85 | 29.13 | 24.04 | 21.78 | 19.12 | 16.76 | 14.78 | 13.60 | 12.82 | 39.92 |
Operating CF per Share |
1.59 | 1.88 | 2.07 | 1.48 | 1.16 | 0.70 | 0.25 | 0.17 | 0.27 | (1.82) |
Capex per Share |
(0.25) | (0.21) | (0.21) | (0.11) | (0.14) | (0.15) | (0.18) | (0.18) | (0.17) | (0.24) |
Free Cash Flow per Share |
1.34 | 1.68 | 1.86 | 1.36 | 1.02 | 0.56 | 0.07 | (0.01) | 0.09 | (2.06) |
Cash per Share |
1.44 | 2.40 | 1.92 | 1.62 | 0.66 | 0.55 | 0.43 | 0.26 | 0.31 | 0.41 |
Shareholders Equity per Share |
8.18 | 8.18 | 7.94 | 7.65 | 6.54 | 5.61 | 5.80 | 4.23 | (0.59) | 1.64 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.18 | 8.18 | 7.94 | 7.65 | 6.54 | 5.61 | 5.80 | 4.23 | (0.59) | 1.64 |
Free Cash Flow |
217.14 | 287.79 | 333.17 | 246.86 | 182.94 | 100.52 | 11.19 | (1.85) | 13.40 | (48.23) |
Working Capital |
435.62 | 542.48 | 475.95 | 428.99 | 250.56 | 222.99 | 228.65 | 227.43 | 81.46 | 43.18 |
Capital Expenditures |
(41.31) | (35.61) | (38.12) | (20.69) | (25.63) | (26.87) | (28.28) | (26.28) | (24.47) | (5.69) |
Net Current Asset Value |
(864.41) | (694.88) | (701.11) | (732.49) | (904.78) | (974.70) | (1,124.07) | (357.96) | (501.25) | (393.28) |
EV/EBIT |
18.03 | 14.54 | 21.80 | 25.44 | 31.76 | 34.81 | 0.00 | 66.36 | 79.98 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
15.28 | 12.37 | 19.52 | 22.24 | 26.80 | 25.56 | 0.00 | 53.22 | 63.99 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 0.53 | 0.55 | 0.64 | 0.66 | 0.69 | 0.47 | 0.47 | 1.52 | 0.80 |
Cash ROIC |
7.98% | 9.83% | 11.78% | 8.99% | 7.75% | 4.49% | 0.49% | (0.16%) | 3.04% | (9.65%) |
Accounts Receivable Turnover |
12.79 | 12.70 | 11.39 | 11.02 | 10.32 | 9.29 | 7.28 | 9.80 | 18.79 | 9.06 |
Accounts Payable Turnover |
7.30 | 7.68 | 8.25 | 9.35 | 9.46 | 9.33 | 8.79 | 11.96 | 21.20 | 10.40 |
Inventory Turnover |
10.62 | 12.04 | 13.33 | 15.11 | 15.56 | 17.13 | 18.04 | 25.00 | 37.25 | 17.02 |
Average Days of Payables |
51.20 | 55.94 | 46.88 | 44.92 | 38.33 | 43.94 | 44.89 | 45.19 | 17.42 | 34.91 |
Days of Inventory on Hand |
37.70 | 35.55 | 30.11 | 26.60 | 25.13 | 24.63 | 23.53 | 20.04 | 10.05 | 19.60 |
Average Receivables |
441.65 | 393.70 | 377.60 | 357.89 | 333.29 | 326.38 | 317.29 | 197.85 | 97.30 | 103.22 |
Average Payables |
625.30 | 518.65 | 402.64 | 329.00 | 281.08 | 251.99 | 204.47 | 126.92 | 65.19 | 64.75 |
Average Inventory |
429.64 | 331.07 | 249.14 | 203.69 | 170.85 | 137.24 | 99.61 | 60.69 | 37.10 | 39.57 |
Average Assets |
3,438.76 | 3,319.39 | 3,164.99 | 2,951.93 | 2,719.18 | 2,618.49 | 2,008.88 | 1,015.65 | 604.04 | 567.81 |
Average Common Equity |
1,365.32 | 1,412.96 | 1,403.89 | 1,280.99 | 1,095.81 | 961.28 | 754.83 | 259.04 | (59.19) | (57.25) |
Columns are period end dates · fundamentals updated 5 Nov 2026